Guide for Authors  by unknown
The Journal of the Formosan Medical Association (JFMA) is 
the official peer-reviewed and SCI-indexed journal of the 
Formosan Medical Association, which is based in Taipei, 
Taiwan. The Journal is published every month by Elsevier.
Authors are welcome to submit original contributions 
relating to all fields of medicine and allied disciplines 
that are of interest to the medical profession.
The Editorial Board requires authors to be in 
compliance with the Uniform Requirements for 
Manuscripts Submitted to Biomedical Journals (URMs), 
which are compiled by the International Committee of 
Medical Journal Editors (ICMJE); current URMs are 
available at http://www.icmje.org.
1. Manuscript Submission 
1.1. Online submission 
Manuscripts (meaning all submission items, including all 
text, tables, artwork, cover letter, conflicts of interest 
disclosures, and any other required documents/material) 
must be submitted online to the JFMA through the Elsevier 
Editorial System (EES) at http://ees.elsevier.com/jfma. 
This site will guide authors stepwise through the submission 
process. If assistance is required, please refer to the 
tutorials for authors and/or customer support that are 
available on the EES website; you may also contact the 
Editorial Office. Please do not post, fax or e-mail your 
manuscripts to the Editorial Office. 
 Editorial Office 
 Journal of the Formosan Medical Association
 Formosan Medical Association
 1, Chang-Te Street
 Taipei 100, Taiwan 
 Tel: (+886) (0)2 2381-0367 
 Fax: (+886) (0)2 2389-6716
 E-mail: jfmaed@fma.org.tw
1.2. Important Information
• Articles should be in Microsoft Word document format 
and prepared in the simplest form possible. We will 
add in the correct font, font size, margins and so on 
according to the Journal’s style.
• You may use automatic page numbering, but do NOT 
use other kinds of automatic formatting such as 
footnotes, headers and footers.
• Put text, references, table headings and tables, and 
figure legends in one file.
• Figures must be submitted as separate picture files, at 
the correct resolution and named according to the 
figure number and format, e.g., “Fig1.tif”, “Fig2.jpg”. 
Please see section 9.8. for more information.
1.3. Supporting Documents
The following documents must be included in your 
submission and uploaded to EES (refer also to the 
Checklist that follows these author instructions). Items 
(1), (2) and (3) are mandatory. Items (4) and (5) are 
required only if they are applicable to your manuscript.
(1)  Cover Letter. This must include the following infor-
mation: 
• title of the manuscript
• names (spelled out in full) of all the authors*, and the 
institutions with which they are affiliated; indicate all 
affiliations with a superscripted lowercase letter after 
the author's name and in front of the matching affilia-
tion (*the name of each author should be written with 
the family name last, e.g., Wan-Lin Chang) corre-
sponding author details (name, e-mail, mailing 
address, telephone and fax numbers)
• a statement that the material contained in the manu-
script has not been previously published and is not 
being concurrently submitted elsewhere
• persons who do not fulfill the requirements to be listed 
as authors but who nevertheless contributed to the 
manuscript (such as those who provided writing assist-
ance, for example) should be disclosed
• the signature of the corresponding author
• Optional: if you have a list of reviewers who you wish 
to review or not to review your manuscript, you may 
include this list in the cover letter
(2)  Authorship & Conflicts of Interest Statement. Each 
author’s contribution to the manuscript should be 
listed. Any and all potential and actual conflicts of 
interest should also be listed (see Section 2 for more 
information). Please use the JFMA Authorship & 
Conflicts of Interest Statement form that follows these 
author instructions and that is also provided on the 
Journal’s website at www.jfma-online.com. The corre-
sponding author is to sign on behalf of all the authors 
listed in the manuscript and is responsible for ensuring 
the accuracy of the information provided.
(3)  Copyright Transfer Agreement. In the event that your 
manuscript is accepted for publication in the JFMA, you 
are required to transfer all copyright ownership in and 
relating to the work to the Formosan Medical Association 
and Elsevier. Please use the JFMA Copyright Transfer 
Agreement form that follows these author instructions 
and that is also provided on the Journal’s website at 
www.jfma-online.com. The corresponding author is to 
sign on behalf of all the authors listed in the manuscript 
and is responsible for ensuring that all coauthors under-
stand and agree with the terms in the form.
(4)  Signed Statement of Informed Consent. Articles where 
human subjects can be identified in descriptions, pho-
tographs or pedigrees must be accompanied by a 
signed statement of informed consent to publish (in 
print and online) the descriptions, photographs and 
pedigrees from each subject who can be identified. 
See Section 5 for more information.
(5)  Copyright Permission. If you have reproduced or 
adapted material from other copyrighted sources, 
the letter(s) of permission from the copyright holder(s) 
to reproduce or adapt the copyrighted sources must be 
supplied. Otherwise, such material must be removed 
from your manuscript.
2. Disclosure of Conflicts of Interest
A conflict of interest occurs when an individual’s 
objectivity is potentially compromised by a desire for 
financial gain, prominence, professional advancement or 
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a successful outcome. JFMA Editors strive to ensure 
that what is published in the Journal is as balanced, 
objective and evidence-based as possible. Since it can 
be difficult to distinguish between an actual conflict of 
interest and a perceived conflict of interest, the Journal 
requires authors to disclose all and any potential 
conflicts of interest.
Conflicts of interest may be financial or non-financial. 
Financial conflicts include financial relationships such as 
honoraria; educational grants; participation in speakers’ 
bureaus; membership, employment, consultancies, stock 
ownership, or other equity interest; expert testimony or 
patent-licensing arrangements. Non-financial conflicts 
include personal or professional relationships, affiliations, 
academic competition, intellectual passion, knowledge 
or beliefs that might affect objectivity.
Please ensure that the name of each author listed in 
your manuscript appears in either Section I or Section II 
on page 2 of the JFMA Authorship & Conflicts of 
Interest Statement form (an author’s name cannot 
appear in both Section I and Section II of the form).
3.  Ethical Approval of Studies and Informed 
Consent
For human or animal experimental investigations, 
appropriate institutional review board or ethics 
committee approval is required, and such approval, 
including the official approval code, should be stated 
in the methods section of the manuscript. For those 
investigators who do not have formal ethics review 
committees, the principles outlined in the Declaration 
of Helsinki should be followed (World Medical 
Association. Declaration of Helsinki: ethical principles 
for medical research involving human subjects. 
Available at: http://www.wma.net/en/30publications/ 
10policies/b3/17c.pdf).
For investigation of human subjects, state explicitly 
in the methods section of the manuscript that informed 
consent was obtained from all participating adult 
subjects and from parents or legal guardians for minors 
or incapacitated adults, together with the manner in 
which informed consent was obtained (e.g., oral or 
written).
For work involving animals, the guidelines for their 
care and use that were followed should be stated in 
the methods section of the manuscript. For those 
investigators who do not have formal institutional 
guidelines relating to animal experiments, the 
European Commission Directive 86/609/EEC for animal 
experiments (available at http://ec.europa.eu/
environment/chemicals/lab_animals/legislation_en.
htm) should be followed and the same should be stated 
in the methods section of the manuscript.
4. Reporting Clinical Trials
The JFMA has adopted the ICMJE proposal that requires, 
as a condition of consideration for publication of clinical 
trials, registration in a public trials registry. Purely 
observational studies (those in which the assignment of 
the medical intervention is not at the discretion of the 
investigator) will not require registration. Further 
information can be found at http://www.icmje.org.
5.  Identification of Patients in Descriptions, 
Photographs and Pedigrees
A signed statement of informed consent to publish (in 
print and online) patient descriptions, photographs and 
pedigrees should be obtained from all persons (parents 
or legal guardians for minors) who can be identified 
(including by the patients themselves) in such written 
descriptions, photographs or pedigrees. Such persons 
should be shown the manuscript before its submission. 
Omitting data or making data less specific to de-identify 
patients is acceptable, but changing any such data is not 
acceptable.
State explicitly in the methods section of the 
manuscript that informed consent was obtained from 
all participating adult subjects or from parents or legal 
guardians for minors or incapacitated adults, together 
with the manner in which informed consent was 
obtained (i.e., oral or written).
6. Previous Publication or Duplicate Submission
Submitted manuscripts are considered with the 
understanding that they have not been published 
previously in print or electronic format (except in abstract 
or poster form) and are not under consideration in totality 
or in part by another publication or electronic medium.
7. Basic Criteria
Articles should be written in English, using American 
English spelling, and meet the following basic criteria: 
the material is original, the information is important, 
the writing is clear and concise, the study methods are 
appropriate, the data are valid, and the conclusions are 
reasonable and supported by the data.
For manuscripts that are judged by JFMA Editors to 
be written in poor English but otherwise worthy of 
consideration for publication, authors are required to 
pay for the English polishing of their manuscript. 
Otherwise, the Editorial Office reserves the right to 
reject the manuscript. 
8. Article Categories 
The categories of articles that are published in the 
Journal are listed and described below. Please select 
the category that best describes your paper. If your 
paper does not fall into any of these categories, please 
contact the Editorial Office.
For residents of Taiwan, at least one author must be 
a member of the Formosan Medical Association, except 
for those who have been invited to contribute.
8.1. Perspectives
These are comments on recent news or groundbreaking 
work and should provide a short review of the current 
state of research and explain the importance of the 
new findings. Perspectives on papers previously 
published in the JFMA should add a different viewpoint 
to the research and should not merely be a repetitive 
summary of the original paper. Although many of the 
Perspectives published in the Journal are normally 
invited, unsolicited Perspectives are welcome and will 
be given due consideration.
Format guide
• Author: 3 or less
• Word limit: 800 words
• References: 8 or less
• Tables/Figures: 1 maximum
8.2. Review Articles
These should aim to provide the reader with a balanced 
overview of an important and topical issue in research 
or clinical practice. They should cover aspects of a 
topic in which scientific consensus exists as well as 
aspects that remain controversial and are the subject 
of ongoing scientific research. All articles and data 
sources reviewed should include information about the 
specific type of study or analysis, population, inter-
vention, exposure, and tests or outcomes. All articles or 
data sources should be selected systematically for 
inclusion in the review and critically evaluated.
Format guide
• Word limit: 3500 words
• Abstract: unstructured, up to 250 words 
• References: 100 or less
• Tables/Figures: 6 maximum
8.3. Invited Articles
The format for invited articles is jointly decided by 
JFMA Editors and the contributing author.
8.4. Original Articles
These articles typically include randomized trials, 
intervention studies, studies of screening and diagnostic 
tests, laboratory and animal studies, cohort studies, 
cost-effectiveness analyses, case-control studies, and 
surveys with high response rates, which represent new 
and significant contributions to the field.
Section headings should be: Abstract, Introduction, 
Methods, Results, Discussion, Acknowledgments (if any), 
and References.
The Introduction should provide a brief background to 
the subject of the paper, explain the importance of the 
study, and state a precise study question or purpose.
The Methods section should describe the study 
design and methods (including the study setting and 
dates, patients/participants with inclusion and 
exclusion criteria, patient samples or animal specimens 
used, the essential features of any interventions, the 
main outcome measures, the laboratory methods 
followed, or data sources and how these were selected 
for the study), and state the statistical procedures 
employed in the research.
The Results section should comprise the study 
results presented in a logical sequence, supplemented 
by tables and/or figures. Take care that the text does 
not repeat data that are presented in tables and/or 
figures. Only emphasize and summarize the essential 
features of the main results.
The Discussion section should be used to emphasize 
the new and important aspects of the study, placing 
the results in context with published literature, the 
implications of the findings, and the conclusions that 
follow from the study results.
Format guide
• Word limit: 3500 words
• Abstract: structured, up to 250 words 
• References: 40 or less
• Tables/Figures: 6 maximum
8.5. Case Reports
These are short discussions of a case or case series with 
unique features not previously described that make an 
important teaching point or scientific observation. They 
may describe novel techniques or use of equipment, or 
new information on diseases of importance. Section 
headings should be: Abstract, Introduction, Case 
Report, Discussion, Acknowledgments (if any), and 
References.
The Introduction should describe the purpose of the 
present report, the significance of the disease and its 
specificity, and briefly review the relevant literature.
The Case Report should include statements of the 
problem, patient history, diagnosis, treatment, outcome 
and any other information pertinent to the case(s).
The Discussion should compare, analyze and discuss 
the similarities and differences between the reported 
case and similar cases reported in other published 
articles. The importance or specificity of the case 
should be restated when discussing the differential 
diagnoses. Suggest the prognosis of the disease and 
possibility of prevention.
Note that the rejection rate for case reports is much 
higher than for other article categories due to the 
current situation of a large number of case reports 
being submitted. JFMA Editors may request case 
reports to be formatted as correspondence under most 
circumstances.
Format guide
• Word limit: 2000 words
• Abstract: unstructured, up to 250 words 
• References: 25 or less
• Tables/Figures: 3 maximum
8.6. Brief Communications
These reports should be concise presentations of 
preliminary experimental results, instrumentation and 
analytical techniques, or aspects of clinical or 
experimental practice that are not fully investigated, 
verified or perfected but which may be of widespread 
interest or application. The Editors reserve the right to 
decide what constitutes a Brief Communication.
Format guide
• Word limit: 1500 words
• Abstract: unstructured, up to 150 words 
• References: 20 or less
• Tables/Figures: 2 maximum
• No subheadings
8.7. Correspondence
These include short case reports, technical or clinical 
notes and short comments on previously published 
articles. The Editors reserve the right to decide what 
constitutes a Correspondence.
Format guide
• Author: 4 or less
• Word limit: 500 words 
• References: 5 or less
• Tables/Figures: 1 maximum
8.8. Letters to the Editor
Brief letters of constructive comments in response to 
previously published JFMA articles are welcome. Letters 
should have a title. Ensure that the corresponding 
author’s mailing and e-mail addresses are included. 
Letters are edited, sometimes extensively, to sharpen 
their focus. They may be sent for peer review at the 
discretion of JFMA Editors. Letters are selected based 
on clarity, significance, and space.
Format guide
• Author: 4 or less
• Word limit: 400 words 
• References: 4 or less
• Tables/Figures: 1 maximum
9. Manuscript Preparation
Text should be typed double-spaced on white A4 (297  
210 mm) paper, with outer margins of 2.5 cm. The 
manuscript should include a title page, abstract, main 
text, acknowledgments (if any), references, and figures 
and tables as appropriate. Each section of the manuscript 
should begin on a new page. Pages should be numbered 
consecutively, beginning with the title page.
9.1. Title Page 
The title page should contain the following information 
(in order, from the top to bottom of the page):
• article category
• article title
• declaration of any potential financial and non-
financial conflicts of interest
• running title not exceeding 50 characters
• IMPORTANT: please do NOT include any author names 
and affiliations or corresponding author information 
on the title page (this information should be listed in 
your cover letter instead) because the JFMA follows a 
double-blind peer review process
9.2. Abstracts and Keywords
An abstract and 3–5 relevant keywords (in alphabetical 
order) are required for the following article categories: 
Review Articles, Invited Articles, Original Articles, Case 
Reports and Brief Communications.
Abstracts for Review Articles, Invited Articles, Case 
Reports and Brief Communications should be unstructured 
(in one single paragraph with no section headings), be no 
more than 200 words long and include information on the 
background/purpose of the report, methods, results (or 
case report), and conclusions.
Abstracts for Original Articles should be structured 
into the sections listed below and be no more than 250 
words long.
Background/Purpose: briefly explain the importance 
of the study topic and state a precise study question or 
purpose.
Methods: briefly introduce the methods used to perform 
the study; include information on the study design, setting, 
subjects, interventions, outcome measures and analyses as 
appropriate.
Results: briefly present the significant results, with 
data and statistical details such as p values where 
appropriate; be sure that information in the abstract 
matches that in the main text.
Conclusion: state the meaning of your findings, being 
careful to address the study question directly and to 
confine your conclusions to aspects covered in the abstract; 
give equal emphasis to positive and negative findings.
Keywords should be taken from the Medical Subject 
Headings (MeSH) list of Index Medicus (http://www.nlm.
nih.gov/mesh/meshhome.html).
No abstract or keywords are required for Perspectives, 
Correspondence and Letters to the Editor.
9.3. Main Text
The text for Original Articles and Brief Communications 
should be organized into the following sections: 
Introduction, Materials (or Patients) and Methods, Results, 
Discussion, and References. Subheadings in long papers 
are acceptable if needed for clarification and ease of 
reading. Sections for Case Reports are: Introduction, Case 
Report, Discussion, and References. Each section should 
begin on a new page. 
9.3.1. Abbreviations
Where a term/definition will be continually referred 
to, it must be written in full when it first appears in 
the text, followed by the subsequent abbreviation in 
parentheses. Thereafter, the abbreviation may be 
used. An abbreviation should not be first defined in 
any section heading; if an abbreviation has previously 
been defined in the text, then the abbreviation may be 
used in a subsequent section heading. Restrict the 
number of abbreviations to those that are absolutely 
necessary.
9.3.2. Numbers
Numbers that begin a sentence or those that are less than 
10 should be spelled out using letters. Centuries and 
decades should be spelled out, e.g., the Eighties or 
nineteenth century. Laboratory parameters, time, 
temperature, length, area, mass, and volume should be 
expressed using digits. 
9.3.3. Units
Système International (SI) units must be used, with the 
exception of blood pressure values which are to be reported 
in mmHg. Use the metric system for the expression of 
length, area, mass, and volume. Temperatures are to be 
given in degrees Celsius. 
9.3.4. Names of drugs, devices and other products
Use the Recommended International Non-proprietary 
Name (rINN) for medicinal substances, unless the 
specific trade name of a drug is directly relevant to the 
discussion. Generic drug names should appear in 
lowercase letters in the text. If a specific proprietary 
drug needs to be identified, the brand name may appear 
only once in the manuscript in parentheses following 
the generic name the first time the drug is mentioned in 
the text.
For devices and other products, the specific brand 
or trade name, the manufacturer and their location 
(city, state, country) should be provided the first time 
the device or product is mentioned in the text, for 
example, “…IBM SPSS Statistics 21.0 was used (IBM 
Corp., Armonk, NY, USA)”. Thereafter, the generic term 
(if appropriate) should be used.
9.3.5. Gene nomenclature
Current standard international nomenclature for genes 
should be adhered to. For human genes, use genetic 
notation and symbols approved by the HUGO Gene 
Nomenclature Committee (http://www.genenames.
org). You may also refer to the resources available on 
PubMed at http://www.ncbi.nlm.nih.gov/guide/genes-
expression. The Human Genome Variation Society has a 
useful site that provides guidance in naming mutations 
at http://www.hgvs.org/mutnomen/index.html. In your 
manuscript, genes should be typed in italic font and 
include the accession number.
9.3.6. Statistical requirements
Statistical analysis is essential for all research papers 
except Case Reports. Use correct nomenclature for 
statistical methods (e.g., two sample t test, not unpaired 
t test). Descriptive statistics should follow the scales used 
in data description. Inferential statistics are important for 
interpreting results and should be described in detail.
All p values should be presented to the third decimal 
place for accuracy. The smallest p value that should be 
expressed is p < 0.001 since additional zeros do not 
convey useful information; the largest p value that should 
be expressed is p > 0.99. 
9.3.7. Personal communications and unpublished data
These sources cannot be included in the references list 
but may be described in the text. The author(s) must 
give the full name and highest academic degree of the 
person, the date of the communication, and indicate 
whether it was in oral or written (letter, fax, e-mail) 
form. A signed statement of permission should be 
included from each person identified as a source of 
information in a personal communication or as a source 
for unpublished data.
9.4. Funding/Support Statement
All financial and material support for the research, 
work, writing and editorial assistance from internal or 
external agencies, including commercial companies, 
should be clearly and completely identified in a 
Funding/Support Statement.
9.5. Acknowledgments
General acknowledgments for consultations and 
statistical analyses should be listed concisely, including 
the names of the individuals who were directly involved. 
Consent should be obtained from those individuals 
before their names are listed in this section. Those 
acknowledged should not include secretarial, clerical or 
technical staff whose participation was limited to the 
performance of their normal duties.
9.6. References 
Authors are responsible for the accuracy and 
completeness of their references and for correct in-text 
citation.
9.6.1. In the main text, tables and figure legends
• References should be indicated by superscripted 
numbers according to order of appearance in the 
text, and placed after punctuation. [The actual 
authors can be referred to, but the reference 
number(s) must always be given.]
• References cited in tables or figure legends should 
be included in sequence at the point where the 
table or figure is first mentioned in the main text.
• Do not cite abstracts unless they are the only 
available reference to an important concept.
• Do not cite uncompleted work or work that has not 
yet been accepted for publication (i.e., “unpublished 
observation”, “personal communication”) as 
references. Also see Section 9.3.7.
9.6.2. In the references list 
• References should be compiled at the end of the 
manuscript according to the order of citation in the text.
• References should be limited to those cited in the 
text only.
• Journal references should include, in order, authors’ 
surnames and initials, article title, abbreviated journal 
name, year, volume and inclusive page numbers.
• The surnames and initials of all the authors up to 6 
should be included, but when authors number 7 or 
more, list the first 6 authors only followed by “et al”.
• Abbreviations for journal names should conform to 
those used in MEDLINE.
• If citing a website, provide the author information, 
article title, website address and the date you 
accessed the information.
• Reference to an article that is in press must state the 
journal name and, if possible, the year and volume. 
Examples of the most common reference types are 
provided below. (Please pay particular attention to the 
formatting, word capitalization, spacing and style.)
Standard journal articles
Wu UI, Wang JT, Ho YC, Pan SC, Chen YC, Chang SC. Factors 
associated with development of complications among 
adults with influenza: a 3-year prospective analysis. J 
Formos Med Assoc 2012;111:364—9.
Chen JC, Huang AJ, Chen SC, Wu JL, Wu WM, Chiang HS, et 
al. Interleukin-27 and interleukin-12 augment activation 
of distinct cord blood natural killer cells responses via 
STAT3 pathways. J Formos Med Assoc 2012;111:275—83.
Journal supplement
Kaplan NM. The endothelium as prognostic factor and 
therapeutic target: what criteria should we apply? J 
Cardiovasc Pharmacol 1998;32(Suppl 3):S78—80.
Journal article not in English but with English abstract
Hofele C, Schwager-Schmitt M, Volkmann M. Prognostic 
value of antibodies against p53 in patients with oral squa-
mous cell carcinoma—five years survival rate. Laryngor-
hinootologie 2002;81:342—5. [In German, English abstract]
Book with edition
Bradley EL. Medical and surgical management. 2nd ed. 
Philadelphia: Saunders; 1982.
Book with editors
Letheridge S, Cannon CR, editors. Bilingual education: 
teaching English as a second language. New York: 
Praeger; 1980.
Book chapter in book with editor and edition
Greaves M, Culligan DJ. Blood and bone marrow. In: 
Underwood JCE, editor. General and systematic pathology. 
4th ed. London: Churchill Livingstone; 2004, p. 615—72.
Book series with editors
Wilson JG, Fraser FC, editors. Handbook of teratology, 
vols. 1—4. New York: Plenum Press; 1977—1978.
Bulletin
World Health Organization. World health report 2002: 
reducing risk, promoting healthy life. Geneva, 
Switzerland: World Health Organization; 2002.
Electronic publications
Duchin JS. Can preparedness for biological terrorism save 
us from pertussis? Arch Pediatr Adolesc Med 2004;158(2). 
Available at http://archpedi.ama-assn.org/cgi/content/
full/158/2/106. Accessed June 12, 2004.
Smeeth L, Iliffe S. Community screening for visual 
impairment in the elderly. Cochrane Database Syst Rev 
2002(2):CD001054. Doi:10.1002/14651858.CD1001054.
Item presented at a meeting but not yet published
Khuri FR, Lee JJ, Lippman SM. Isotretinoin effects on 
head and neck cancer recurrence and second primary 
tumors. In: Proceedings from the American Society of 
Clinical Oncology, May 31—June 3, 2003; Chicago, IL, 
abstract 359.
Item presented at a meeting and published
Cionni RJ. Color perception in patients with UV- or 
bluelight-filtering IOLs. In: Symposium on cataract, IOL, 
and refractive surgery. San Diego, CA: American Society of 
Cataract and Refractive Surgery; 2004, abstract 337.
Thesis
Ayers AJ. Retention of resin restorations by means of 
enamel etching and by pins. MSD thesis, Indiana University 
School of Dentistry, Indianapolis, 1971.
Website
Glueckauf RL, Whitton J, Baxter J. Videocounseling for 
families of rural teens with epilepsy—project update. 
Telehealth News 1998. Available at http://www.
telehealth.net/subscribe/newslettr_4a.html#1. Accessed 
November 15, 2008.
Company/manufacturer publication/pamphlet
Eastman Kodak Company, Eastman Organic Chemicals. 
Catalog no. 49. Rochester, NY: Eastman Kodak; 1977, p. 2—3.
9.7. Tables
Tables should supplement, not duplicate, the text. 
They should have a concise table heading, be self-
explanatory, and numbered consecutively in the order 
of their citation in the text. Items requiring explanatory 
footnotes should be denoted using superscripted 
lowercase letters (a, b, c, etc.), with the footnotes 
arranged under the table in alphabetical order. 
Asterisks (*, **) are used only to indicate the probability 
level of tests of significance. Abbreviations used in the 
table must be defined and placed after the footnotes in 
alphabetical order. If you include a block of data or 
table from another source, whether published or 
unpublished, you must acknowledge the original 
source.
9.8. Figures
9.8.1. General guidelines 
The number of figures should be restricted to the 
minimum necessary to support the textual material. 
Figures should have an informative figure legend and 
be numbered in the order of their citation in the text. 
All symbols and abbreviations should be defined in the 
figure legend in alphabetical order. Items requiring 
explanatory footnotes should follow the same style as 
that for tables as described in Section 9.7.
Patient identification should be obscured. All 
lettering should be done professionally and should be 
in proportion to the drawing, graph or photograph. 
Photomicrographs must include an internal scale 
marker, and the legend should state the type of 
specimen, original magnification and stain.
Figures must be submitted as separate picture files, 
at the correct resolution (see Section 9.8.2.) and 
named according to the figure number and format, 
e.g., “Fig1.tif”, “Fig2.jpg”.
9.8.2. Formats
Regardless of the application used, when your electronic 
artwork is finalized, please “save as” or convert the 
images to one of the following formats (note the 
resolution requirements for line drawings, halftones, 
and line/halftone combinations given below):
• EPS: vector drawings. Embed the font or save the 
text as “graphics”.
• TIFF: color or grayscale photographs (halftones)—
use a minimum of 300 dpi.
• TIFF: bitmapped line drawings—use a minimum of 
1000 dpi.
• TIFF: combination of bitmapped line/halftone (color 
or grayscale)—use a minimum of 600 dpi.
• DOC, XLS or PPT: if your electronic artwork is 
created in any of these Microsoft Office applications, 
please supply “as is”. 
Please do not: 
• Supply files that do not meet the resolution 
requirements detailed above;
• Supply files that are optimized for screen use (such 
as GIF, BMP, PICT, WPG) as the resolution is too low;
• Submit graphics that are disproportionately large 
for the content. 
A detailed guide on electronic artwork is available at 
http://www.elsevier.com/artworkinstructions. Please 
note that the cost of color illustrations will be 
charged to the author (see Section 12 for more 
information).
10. The Editorial and Peer Review Process
As a general rule, the receipt of a manuscript will be 
acknowledged within 2 weeks of submission, and 
authors will be provided with a manuscript reference 
number for future correspondence. If such an 
acknowledgment is not received in a reasonable period 
of time, the author should contact the Editorial Office.
Submissions are reviewed by the Editorial Office to 
ensure that it contains all parts. Submissions will be 
rejected if the author has not supplied all the 
material and documents as outlined in these author 
instructions.
Manuscripts are then forwarded to the Editor-in-
Chief, who makes an initial assessment of it. If the 
manuscript does not appear to be of sufficient merit or 
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